DEPLOY

Buying guide

Samsung Galaxy Watch (and Galaxy Ring) vs Stelo in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

  • Samsung Galaxy Watch (and Galaxy Ring) has more capabilities independently verified as autonomous (1 vs 0).
  • Stelo has the lower recorded price.
Attribute
No image on file
Samsung Galaxy Watch (and Galaxy Ring)View full model page →
Trying a Dexcom G7 sample for my Diabadass #diabetes #t1d #dexcom #dexcomg7 #typeonediabetes
SteloView full model page →
ManufacturerSamsung ElectronicsDexcom
Form factorbiometricbiometric
Maturitycommercialcommercial
Autonomy✓ 1 verified autonomous—
Availabilityshipping-nowshippingshipping-nowshipping
Price$300-$399 (actual sale price)$89-$99 (actual sale price)
Capability claims
  • Detects irregular heart rhythm (autonomous, verified)
  • Tracks sleep (claimed-only, claimed)
  • Tracks heart health (claimed-only, claimed)
—
Brain——
Verified deployments1Global1Global
Privacy practices10cloud-upload, third-party-sharing, data-sale, data-retention, on-device-processing, location-tracking, biometric-storage, data-sale, data-deletion-control, data-retention4biometric-storage, training-data-use, third-party-sharing, data-deletion-control
Sources on file1811

Editorial summaries

Samsung Galaxy Watch (and Galaxy Ring)

The Samsung Galaxy Watch (the Galaxy Watch 7 anchor at about $300, plus the Watch Ultra and the adjacent Galaxy Ring, all July 2024) is a biometric-primary smartwatch whose BioActive sensor combines optical heart rate, electrical ECG, and bioimpedance. Its FDA-cleared features (held by the Samsung Health Monitor app) include ECG (2021), AFib detection (2023), and sleep-apnea detection (De Novo, February 2024), with no subscription. A within-entity verified-vs-claimed exemplar: Samsung's blood-pressure feature is cleared in Korea and several other markets but NOT in the US, where it remains wellness-grade; DEPLOY surfaces that market-specific clearance variance honestly rather than implying a US clearance. The Galaxy Ring is an adjacent biometric form factor (accelerometer, optical HR, skin temperature for sleep, heart rate, and an Energy Score) with no ECG and no FDA-cleared features.

Stelo

Dexcom's Stelo is the first-ever FDA-cleared over-the-counter (no-prescription) glucose biosensor (De Novo, March 5, 2024; US launch August 26, 2024): a 15-day continuous glucose monitor for adults 18+ not on insulin (type 2 not on insulin, plus non-diabetic users tracking how diet and exercise affect glucose). It is the generative-AI end of the glucose cell: Weekly Insights run on Google Cloud's Vertex AI and Gemini, with AI photo meal-logging and personalized daily recommendations, the AI substance that carries it across the biometric boundary. Pricing is about $89 for a 2-week sensor on a biweekly subscription model (around $99/month). From DexCom (NASDAQ: DXCM), Stelo is the OTC product line, separate from the prescription G7. Cap-flag: the cleared indication is an OTC CGM for adults 18+ not on insulin; it is explicitly NOT cleared for problematic hypoglycemia and has no low-glucose alerts, so it should not be read as a diabetes-management device.

Common questions

What is the difference between Samsung Galaxy Watch (and Galaxy Ring) and Stelo?
Samsung Galaxy Watch (and Galaxy Ring) and Stelo are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
Which is cheaper, Samsung Galaxy Watch (and Galaxy Ring) or Stelo?
Stelo has the lower recorded price on the DEPLOY registry than Samsung Galaxy Watch (and Galaxy Ring). Prices are sourced; see each record for whether the figure is a manufacturer target, an estimate, or an actual sale price.
Is Samsung Galaxy Watch (and Galaxy Ring) or Stelo more autonomous?
Samsung Galaxy Watch (and Galaxy Ring) has more capabilities independently verified as autonomous on the DEPLOY registry than Stelo. DEPLOY counts a capability as autonomous only when verified at a real deployment, not from a demo or a vendor claim.
Which has more verified deployments, Samsung Galaxy Watch (and Galaxy Ring) or Stelo?
Samsung Galaxy Watch (and Galaxy Ring) and Stelo each have 1 verified deployment on the DEPLOY registry (confirmed at named sites with primary sources).

Recent coverage

Related comparisons

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.

Install instructionsDownload for Claude Desktop

Machine-readable: this page as markdown.

← Back to all consumer robots